Renewal Application: Critical Path Public Private Partnerships (U18) Clinical Trials Optional

As part of its Critical Path Initiative, FDA recognizes the need for collaborations established under the terms and conditions of a cooperative agreement to facilitate Critical Path Public-Private Partnerships / Consortia activities. This includes developing innovative, collaborative projects in research, education, and outreach for fostering medical product innovation, enabling the acceleration of medical product development, manufacturing, and translational therapeutics, and enhancing medical product safety.